58 results
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
8 May 24
Mirum Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
4:04pm
a number of our strategic objectives that support both the near- and long-term growth of Mirum while maintaining a strong financial position,” said … , progress across Mirum’s strategic objectives, its near- and long-term growth, the strength of its financial position, the performance of its commercial
8-K
EX-99.2
MIRM
Mirum Pharmaceuticals Inc
8 Jan 24
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
8:30am
across all medicines
Long-term data set showing significant effects on pruritus and event-free survival LIVMARLI® (maralixibat) Oral Solution in ALGS … . 2022;6(9):2379-2390. 3. Thompson R. Serum bile acid control in long-term maralixibat-treated patients is associated with native liver survival
8-K/A
EX-99.4
wbs0wnj
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K/A
EX-99.3
ol8br9apn
2 Nov 23
Financial Statements and Exhibits
4:05pm
8-K
EX-99.1
n8fx8a vtc
13 Oct 23
Other Events
4:16pm
424B5
zrm4i6hfa3 w7tfs
10 Aug 22
Prospectus supplement for primary offering
5:07pm
424B5
6vprsi03vrkf
9 Aug 22
Prospectus supplement for primary offering
12:00am